194 related articles for article (PubMed ID: 38203779)
1. Preclinical Repurposing of Sitagliptin as a Drug Candidate for Colorectal Cancer by Targeting
Shih JW; Wu ATH; Mokgautsi N; Wei PL; Huang YJ
Int J Mol Sci; 2024 Jan; 25(1):. PubMed ID: 38203779
[TBL] [Abstract][Full Text] [Related]
2. Gamma-mangostin isolated from garcinia mangostana suppresses colon carcinogenesis and stemness by downregulating the GSK3β/β-catenin/CDK6 cancer stem pathway.
Wu AT; Yeh YC; Huang YJ; Mokgautsi N; Lawal B; Huang TH
Phytomedicine; 2022 Jan; 95():153797. PubMed ID: 34802869
[TBL] [Abstract][Full Text] [Related]
3. The mechanism of sitagliptin inhibition of colorectal cancer cell lines' metastatic functionalities.
Varela-Calviño R; Rodríguez-Quiroga M; Dias Carvalho P; Martins F; Serra-Roma A; Vázquez-Iglesias L; Páez de la Cadena M; Velho S; Cordero OJ
IUBMB Life; 2021 May; 73(5):761-773. PubMed ID: 33615655
[TBL] [Abstract][Full Text] [Related]
4. METTL14-mediated N6-methyladenosine modification of SOX4 mRNA inhibits tumor metastasis in colorectal cancer.
Chen X; Xu M; Xu X; Zeng K; Liu X; Pan B; Li C; Sun L; Qin J; Xu T; He B; Pan Y; Sun H; Wang S
Mol Cancer; 2020 Jun; 19(1):106. PubMed ID: 32552762
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-320 suppresses colorectal cancer by targeting SOX4, FOXM1, and FOXQ1.
Vishnubalaji R; Hamam R; Yue S; Al-Obeed O; Kassem M; Liu FF; Aldahmash A; Alajez NM
Oncotarget; 2016 Jun; 7(24):35789-35802. PubMed ID: 27119506
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of SOX4 is associated with colorectal cancer progression.
Wang B; Li Y; Tan F; Xiao Z
Tumour Biol; 2016 Jul; 37(7):9131-7. PubMed ID: 26768610
[TBL] [Abstract][Full Text] [Related]
7. Network-based screening identifies sitagliptin as an antitumor drug targeting dendritic cells.
Ng II; Zhang J; Tian T; Peng Q; Huang Z; Xiao K; Yao X; Ng L; Zeng J; Tang H
J Immunother Cancer; 2024 Mar; 12(3):. PubMed ID: 38458637
[TBL] [Abstract][Full Text] [Related]
8. Preclinical Evaluation of a Novel Small Molecule LCC-21 to Suppress Colorectal Cancer Malignancy by Inhibiting Angiogenic and Metastatic Signatures.
Mokgautsi N; Kuo YC; Huang YJ; Chen CH; Mukhopadhyay D; Wu ATH; Huang HS
Cells; 2023 Jan; 12(2):. PubMed ID: 36672201
[TBL] [Abstract][Full Text] [Related]
9. Sitagliptin: a potential drug for the treatment of COVID-19?
Bardaweel SK; Hajjo R; Sabbah DA
Acta Pharm; 2021 Jun; 71(2):175-184. PubMed ID: 33151168
[TBL] [Abstract][Full Text] [Related]
10. MiR-363-3p inhibits the epithelial-to-mesenchymal transition and suppresses metastasis in colorectal cancer by targeting Sox4.
Hu F; Min J; Cao X; Liu L; Ge Z; Hu J; Li X
Biochem Biophys Res Commun; 2016 May; 474(1):35-42. PubMed ID: 27084453
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA‑129 inhibits colorectal cancer cell proliferation, invasion and epithelial‑to‑mesenchymal transition by targeting SOX4.
Chen Z; Zhong T; Zhong J; Tang Y; Ling B; Wang L
Oncol Rep; 2021 May; 45(5):. PubMed ID: 33760159
[TBL] [Abstract][Full Text] [Related]
12. Exploring novel targets of sitagliptin for type 2 diabetes mellitus: Network pharmacology, molecular docking, molecular dynamics simulation, and SPR approaches.
Qi JH; Chen PY; Cai DY; Wang Y; Wei YL; He SP; Zhou W
Front Endocrinol (Lausanne); 2022; 13():1096655. PubMed ID: 36699034
[TBL] [Abstract][Full Text] [Related]
13. Cancer-associated fibroblasts promote the stemness of CD24
Li Y; Wang R; Xiong S; Wang X; Zhao Z; Bai S; Wang Y; Zhao Y; Cheng B
J Mol Med (Berl); 2019 Feb; 97(2):243-255. PubMed ID: 30564864
[TBL] [Abstract][Full Text] [Related]
14. USP20 regulates the stability of EMT transcription factor SOX4 and influences colorectal cancer metastasis.
Guan Y; Jiang SR; Liu JG; Shi JR; Liu ZB
Pathol Res Pract; 2022 May; 233():153879. PubMed ID: 35405623
[TBL] [Abstract][Full Text] [Related]
15. Preclinical Identification of Sulfasalazine's Therapeutic Potential for Suppressing Colorectal Cancer Stemness and Metastasis through Targeting KRAS/MMP7/CD44 Signaling.
Leung WH; Shih JW; Chen JS; Mokgautsi N; Wei PL; Huang YJ
Biomedicines; 2022 Feb; 10(2):. PubMed ID: 35203586
[TBL] [Abstract][Full Text] [Related]
16. Characterization of cancer stem cells from different grades of human colorectal cancer.
Manhas J; Bhattacharya A; Agrawal SK; Gupta B; Das P; Deo SV; Pal S; Sen S
Tumour Biol; 2016 Oct; 37(10):14069-14081. PubMed ID: 27507615
[TBL] [Abstract][Full Text] [Related]
17. Reduced DAXX Expression Is Associated with Reduced CD24 Expression in Colorectal Cancer.
Chen YC; Lee TH; Tzeng SL
Cells; 2019 Oct; 8(10):. PubMed ID: 31614769
[TBL] [Abstract][Full Text] [Related]
18. Tumor-associated macrophages improve hypoxia-induced endoplasmic reticulum stress response in colorectal cancer cells by regulating TGF-β1/SOX4.
Kang Y; Lv R; Feng Z; Zhu J
Cell Signal; 2022 Nov; 99():110430. PubMed ID: 35933032
[TBL] [Abstract][Full Text] [Related]
19. MiRNA-212 acts as a tumor-suppressor in colorectal carcinoma through targeting SOX4.
Mou TY; Zhang RR; Wang YN
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10751-10760. PubMed ID: 31858542
[TBL] [Abstract][Full Text] [Related]
20. Dipeptidyl Peptidase IV as a Prognostic Marker and Therapeutic Target in Papillary Thyroid Carcinoma.
Lee JJ; Wang TY; Liu CL; Chien MN; Chen MJ; Hsu YC; Leung CH; Cheng SP
J Clin Endocrinol Metab; 2017 Aug; 102(8):2930-2940. PubMed ID: 28575350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
